To help their R&D team secure management approval, Syncro first created prototypes for wireless device/app communications, UI and workflow.
Syncro Medical developed the companion app Dart/Flutter. The app receives usage information from the BLE-enabled device and provides real-time feedback to the patient on drug delivery quality and potential overuse, plus supports a myriad of additional features for physician and patient support and disease management. The data is pushed to the cloud backend for sharing with physicians and other caregivers.
With Syncro Medical’s help, this client was the first-to-market with an FDA-approved connected drug delivery system for asthma patients, confirming this client’s status as a leader in the segment. Syncro Medical is now working on companion apps for this client’s other medication delivery systems.